[1] Wolthuis AM, Tomassetti C. Multidisciplinary laparoscopic treatment for bowel endometriosis[J]. Best Pract Res Clin Gastroenterol, 2014,28(1):53-67. DOI: 10.1016/j.bpg.2013.11.008.
[2] Jenkins S, Olive DL, Haney AF. Endometriosis: pathogenetic implications of the anatomic distribution[J]. Obstet Gynecol, 1986,67(3):335-338.
[3] Colaiacovo R, Carbonari A, Ganc R, et al. Bowel endometriosis mimicking gastrointestinal stromal tumor and diagnosed by endoscopic ultrasound[J]. Endoscopy, 2014,46 Suppl 1 UCTN:E433-434. DOI: 10.1055/s-0034-1377429.
[4] Nezhat C, Li A, Falik R, et al. Bowel endometriosis: diagnosis and management[J]. Am J Obstet Gynecol, 2018,218(6):549-562. DOI: 10.1016/j.ajog.2017.09.023.
[5] Rousset P, Peyron N, Charlot M, et al. Bowel endometriosis: preoperative diagnostic accuracy of 3.0-T MR enterography--initial results[J]. Radiology, 2014,273(1):117-124. DOI: 10.1148/radiol.14132803.
[6] Lattarulo S, Pezzolla A, Fabiano G, et al. Intestinal endometriosis: role of laparoscopy in diagnosis and treatment[J]. Int Surg, 2009,94(4):310-314.
[7] Vercellini P, Somigliana E, Consonni D, et al. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction[J]. Hum Reprod, 2012,27(12):3450-3459. DOI: 10.1093/humrep/des313.
[8] Brown J, Crawford TJ, Allen C, et al. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis[J]. Cochrane Database Syst Rev, 2017,1(1):CD004753. DOI: 10.1002/14651858.CD004753.pub4.
[9] 李爱金,陶爽爽,林丽娜,等. 醋酸亮丙瑞林联合替勃龙治疗子宫内膜异位症的疗效及对患者血清EMAb水平、激素分泌及月经周期的影响[J]. 中国妇幼保健,2020,35(16):3062-3065. DOI:10.19829/j.zgfybj.issn.1001-4411. 2020.16.041.
[10] 黄莉莉,张智勤,杜瑜,等. 醋酸戈舍瑞林联合安宫黄体酮对子宫内膜异位症患者可溶性人类白细胞抗原-G、E-钙黏附蛋白影响[J]. 临床军医杂志,2023,51(3):315-317,320. DOI:10.16680/j.1671-3826.2023.03.27.
[11] 张晖. 促性腺激素释放激素激动剂联合左炔诺孕酮宫内缓释系统对重度子宫内膜异位症患者生育功能的影响[J]. 中国妇幼保健,2022,37(22):4222-4225. DOI:10.19829/j.zgfybj.issn.1001-4411.2022.22.030.
[12] 刘姣. 糖皮质激素联合醋酸戈舍瑞林缓释植入剂对子宫内膜异位症腹腔镜术后患者的影响[J]. 中外医学研究,2022,20(30):52-56. DOI:10.14033/j.cnki.cfmr.2022.30.013.
[13] Moawad NS, Caplin A. Diagnosis, management, and long-term outcomes of rectovaginal endometriosis[J]. Int J Womens Health, 2013,5:753-763. DOI: 10.2147/IJWH.S37846.
[14] Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis[J]. BMJ, 2022,379:e070750. DOI: 10.1136/bmj-2022-070750.
[15] Practice bulletin no. 114: management of endometriosis[J]. Obstet Gynecol, 2010, 116(1):223-236. DOI: 10.1097/AOG.0b013e3181e8b073.
[16] Johnson NP, Hummelshoj L; World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis[J]. Hum Reprod, 2013,28(6):1552-1568. DOI: 10.1093/humrep/det050.
[17] Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis[J]. Hum Reprod, 2014,29(3):400-412. DOI: 10.1093/humrep/det457.
[18] Kuznetsov L, Dworzynski K, Davies M, et al. Diagnosis and management of endometriosis: summary of NICE guidance[J]. BMJ, 2017,358:j3935. DOI: 10.1136/bmj.j3935.
|